Noxafil and Dehydration - a phase IV clinical study of FDA data

Summary:

Dehydration is reported as a side effect among people who take Noxafil (posaconazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zofran, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Dehydration when taking Noxafil. It is created by eHealthMe based on reports of 5,902 people who have side effects when taking Noxafil from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Dehydration?

Dehydration (dryness resulting from the removal of water) is found to be associated with 2,753 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Dehydration.

On Aug, 07, 2026

5,902 people reported to have side effects when taking Noxafil.
Among them, 37 people (0.63%) have Dehydration.

Among these 37 people:

How long have people been on Noxafil when they have Dehydration? *

What is the gender of people who have Dehydration when taking Noxafil? *

female: 60.61 %
male: 39.39 %

What is the age of people who have Dehydration when taking Noxafil? *

What are other drugs people take besides Noxafil? *

What are other side effects people have besides Dehydration? *

Weakness: 12 people, 32.43%
Fatigue (feeling of tiredness): 10 people, 27.03%
Fall: 8 people, 21.62%
Thrombocytopenia (decrease of platelets in blood): 8 people, 21.62%
Nausea (feeling of having an urge to vomit): 8 people, 21.62%
White Blood Cell Count Decreased: 7 people, 18.92%
Rashes (redness): 6 people, 16.22%
Diarrhea: 6 people, 16.22%
Febrile Neutropenia (fever with reduced white blood cells): 6 people, 16.22%
Nausea And Vomiting: 6 people, 16.22%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 12 people, 32.43%
Nausea (feeling of having an urge to vomit): 4 people, 10.81%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 10.81%
Prostatomegaly (enlargement of the prostate): 4 people, 10.81%
Parkinson's Disease: 4 people, 10.81%
Pain: 4 people, 10.81%
Constipation: 4 people, 10.81%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 4 people, 10.81%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 3 people, 8.11%
Graft Versus Host Disease In Skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and have Dehydration?

- Check whether Dehydration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Noxafil:

Noxafil (5,919 reports)

Dehydration treatments and more:

Dehydration (173,274 reports)

Browse all side effects of Noxafil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dehydration:

Dehydration (2,754 drugs)

Browse all the conditions that are associated with Dehydration:

Dehydration (3,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on posaconazole (the active ingredients of Noxafil) and Noxafil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.